Toggle Dropdown
Announcements
Projects
News & Events
Welcome guest
Log in
Loading
Loading...
Announcements
Projects
Orgs
Project
Articles 203
Votes 1
0% interested
Neurologylive.com
Home
Members
Articles
Authors
99
Marco Meglio
NeurologyLive® Staff
Ralph Nixon
MD
PhD
Matt Hoffman
Yolanda A. Yu
DO
Alon Y. Avidan
MPH
Lynn Bekris
Paul Lipkin
Michael Yeaman
Mirla Avila
Michael Levy
Mitzi Williams
Ashgan Elshinawy
Avindra Nath
Christopher Elder
Gregory A. Rippon
MS
Emma Ciafaloni
Brenda L. Banwell
Sean Pittock
Isabella Ciccone
Joe Kardine
OTR
CBIS
Jessica Ailani
Robert Zivadinov
Dalia Rotstein
Benzi Kluger
Patricia Bobryk
MHS
MSCS
PT
ATP
Darina Petrovsky
RN
James E. Galvin
Nicholas Varvel
Deepti Zutshi
FAAN
Dolores Santamaria
Susan Abushakra
Dawn Edhe
Eli Pollard
M. Shazam Hussain
FRCP(C)
FAHA
Tudor Jovin
Ling Wan-Albert
OTD
Xiang Qi
Bei Wu
Marc Agronin
Stephen Scheinthal
DFACN
DFAPA
CS
Marwan Sabbagh
Sarah C. Stoney
MSW
LSW
Cristina A.F. Román
Brent D. Aulston
Afolasade Fakolade
Leigh Charvet
Douglas Sproule
MSc
Joseph Sullivan
Alistair Mackett
Sharon Fekrat
Mitzi Joi Williams
William Kilgo
Mikael Cohen
Melinda Magyari
Michael Y. Sy
Sharon L. Rogers
Jeffrey Cohen
Sarah Anderson
PharmD
NBC-HWC
Alicyn Magruder
BCACP
Bruce Hughes
Robert Naismith
Adam Mecca
Emad Estemalik
Gregory Krauss
Louis Ferrari
RPh
MBA
Danielle Becker
FAES
Neelam Goyal
Ifrah Zawar
Ponni Subbiah
Martha Morrell
1
2
3
4
5
…
Next
»
Rett Syndrome Symptoms and Quality of Life Improvements Through Trofinetide: Ponni Subbiah, MD, MPH - Neurology Live
almost2y
Quantifying Impact of Tuberous Sclerosis Complex-Associated Neuropsychiatric Disorders - Neurology Live
almost2y
This Week on NeurologyLive® — December 18, 2023 - Neurology Live
almost2y
Neurostimulation and Targeted Treatment Delivery in Epilepsy Care: Martha Morrell, MD - Neurology Live
almost2y
Mitochondrial Dysfunction in REM-Sleep Behavior Disorder May Serve as Biomarker for Parkinson Disease - Neurology Live
almost2y
Growing Trofinetide's Long-Term Profile as First Approved Rett Syndrome Therapy: Ponni Subbiah, MD, MPH - Neurology Live
almost2y
This Week on NeurologyLive® — December 11, 2023 - Neurology Live
almost2y
Insights From Comprehensive Research on Epilepsy and Cognitive Decline: Ifrah Zawar, MD - Neurology Live
almost2y
Gene Therapy, Innovative Drugs, Surgical Techniques, and the Evolving Landscape of Epilepsy Care: Gregory Krauss, MD - Neurology Live
almost2y
Balancing New Medications and Reducing Adverse Effects in Epilepsy Treatment: Louis Ferrari, RPh, MBA - Neurology Live
almost2y
Subgroups and Phenotypes of Myasthenia Gravis - Neurology Live
almost2y
Ketogenic Diet Effective and Tolerable to Reduce Seizures in Infants - Neurology Live
almost2y
Emphasizing Patient Conversations and Treatment Opportunities for Seizure Management: Danielle Becker, MD, MS, FAES - Neurology Live
almost2y
The Persistent Challenge of Epilepsy Treatment Through the Ages: Louis Ferrari, RPh, MBA - Neurology Live
almost2y
Embracing New Approaches to Seizure Control Beyond Surgery: Gregory Krauss, MD - Neurology Live
almost2y
CogEx Trial Questions Efficacy of Cognitive Rehabilitation and Exercise for Progressive MS - Neurology Live
almost2y
This Week on NeurologyLive® — November 20, 2023 - Neurology Live
almost2y
Remote Palliative Care Intervention Yields Positive Outcomes in Parkinson Disease and Related Disorders - Neurology Live
almost2y
NeurologyLive® Brain Games: November 19, 2023 - Neurology Live
almost2y
Newly Announced VISION Study Aims to Improve Parkinson DBS Localization Through SIS Brain Visualization Software - Neurology Live
almost2y
Mental and Behavioral Health Symptoms Among Key Predictors of Epilepsy-Specific Health-Related Quality of Life - Neurology Live
almost2y
Episode 102: Potential of Gamma Sensory Stimulation in Alzheimer Disease - Neurology Live
almost2y
Timing of Neurofilament Light Changes May Predict Multiple Sclerosis Worsening - AJMC.com Managed Markets Network
almost2y
Excitement Behind the 2023 American Headache Society Symposium: Emad Estemalik, MD - Neurology Live
almost2y
Mechanistic Potential of Synapse-Targeted Agent ALX-001 for Alzheimer Disease: Adam Mecca, MD, PhD - Neurology Live
almost2y
1
2
3
4
5
…
Next
»
Modal title
...
Profile
Loading profile
Loading...